Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

57.02
Delayed Data
As of Feb 27
 +0.53 / +0.94%
Today’s Change
47.36
Today|||52-Week Range
61.90
-0.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues5.1B5.1B5.0B4.7B
 
 
 
 
 
Cost of Goods Sold1.9B2.0B1.9B1.7B
 
 
 
 
 
Depreciation And Amortization410.8M381.3M355.1M338.0M
 
 
 
 
 
 
Operating ExpensesGross Income2.7B2.7B2.8B2.6B
 
 
 
 
 
General Expenses1.7B1.6B1.6B1.6B
 
 
 
 
 
Research And Development358.9M350.7M405.3M347.1M
 
 
 
 
 
Total Operating Expenses4.0B4.0B3.8B3.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.1B1.1B1.1B1.1B
 
 
 
 
 
Extraordinary Credit--2.0M164.3M131.0M
 
 
 
 
Extraordinary Charge-89.5M-198.8M-178.1M-237.2M
 
 
 
 
 
Interest Expense On Debt82.4M45.9M132.8M153.9M
 
 
 
 
 
Equity In Earnings-8.1M0.00-4.9M7.3M
 
 
 
 
Other Expenses2.0M-4.1M23.6M-25.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income905.9M863.5M1.0B798.7M
 
 
 
 
 
Income Taxes-145.4M-104.0M-157.4M-170.4M
 
 
 
 
 
Minority Interest-4.1M-3.1M-12.8M-6.4M
 
 
 
 
 
Net Income756.5M762.6M861.8M629.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS850.0M852.0M855.0M854.0M
 
 
 
 
 
Shares To Calculate EPS Diluted852.0M857.0M861.0M861.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.89$0.90$1.00$0.73
 
 
 
 
 
EPS Diluted$0.88$0.89$1.00$0.73
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account